tetano
Editor, Senior Moderator
Eur J Clin Microbiol Infect Dis
. 2020 Jun 3.
doi: 10.1007/s10096-020-03923-7. Online ahead of print.
Influenza-associated Aspergillosis in Critically-Ill Patients-A Retrospective Bicentric Cohort Study
Frederike Waldeck[SUP] 1 [/SUP], Filippo Boroli[SUP] 2 [/SUP], No?mie Suh[SUP] 2 [/SUP], Pedro David Wendel Garcia[SUP] 3 [/SUP], Domenica Flury[SUP] 1 [/SUP], Julia Notter[SUP] 1 [/SUP], Anne Iten[SUP] 4 [/SUP], Laurent Kaiser[SUP] 5 [/SUP], Jacques Schrenzel[SUP] 5 [/SUP], Katia Boggian[SUP] 1 [/SUP], Marco Maggiorini[SUP] 3 [/SUP], J?r?me Pugin[SUP] 2 [/SUP], Gian-Reto Kleger[SUP] 6 [/SUP], Werner Christian Albrich[SUP] 7 [/SUP]
Affiliations
Abstract
Influenza was recently reported as a risk factor for invasive aspergillosis (IA). We aimed to describe prognostic factors for influenza-associated IA (IAA) and poor outcome and mortality in critically ill patients in Switzerland. All adults with confirmed influenza admitted to the ICU at two Swiss tertiary care centres during the 2017/2018 influenza season were retrospectively evaluated. IAA was defined by clinical, mycological and radiological criteria: a positive galactomannan in bronchoalveolar lavage or histopathological or cultural evidence in respiratory specimens of Aspergillus spp., any radiological infiltrate and a compatible clinical presentation. Poor outcome was defined as a composite of in-hospital mortality, ICU length of stay (LOS), invasive ventilation for > 7 days or extracorporeal membrane oxygenation. Of 81 patients with influenza in the ICU, 9 (11%) were diagnosed with IAA. All patients with IAA had poor outcome compared to 26 (36%) patients without IAA (p < 0.001). Median ICU-LOS and mortality were 17 vs. 3 days (p < 0.01) and 3/9 (33%) vs. 13/72 (18%; p = 0.37) in patients with vs. without IAA, respectively. Patients with IAA had significantly longer durations of antibiotic therapy, vasoactive support and mechanical ventilation. Aspergillus was the most common respiratory co-pathogen (9/40, 22%) followed by classical bacterial co-pathogens. IAA was not associated with classical risk factors. Aspergillus is a common superinfection in critically ill influenza patients associated with poor outcome and longer duration of organ supportive therapies. Given the absence of classical risk factors for aspergillosis, greater awareness is necessary, particularly in those requiring organ supportive therapies.
Keywords: Influenza; Influenza-associated aspergillosis; Intensive care unit; Invasive aspergillosis; Pneumonia.
. 2020 Jun 3.
doi: 10.1007/s10096-020-03923-7. Online ahead of print.
Influenza-associated Aspergillosis in Critically-Ill Patients-A Retrospective Bicentric Cohort Study
Frederike Waldeck[SUP] 1 [/SUP], Filippo Boroli[SUP] 2 [/SUP], No?mie Suh[SUP] 2 [/SUP], Pedro David Wendel Garcia[SUP] 3 [/SUP], Domenica Flury[SUP] 1 [/SUP], Julia Notter[SUP] 1 [/SUP], Anne Iten[SUP] 4 [/SUP], Laurent Kaiser[SUP] 5 [/SUP], Jacques Schrenzel[SUP] 5 [/SUP], Katia Boggian[SUP] 1 [/SUP], Marco Maggiorini[SUP] 3 [/SUP], J?r?me Pugin[SUP] 2 [/SUP], Gian-Reto Kleger[SUP] 6 [/SUP], Werner Christian Albrich[SUP] 7 [/SUP]
Affiliations
- PMID: 32494955
- DOI: 10.1007/s10096-020-03923-7
Abstract
Influenza was recently reported as a risk factor for invasive aspergillosis (IA). We aimed to describe prognostic factors for influenza-associated IA (IAA) and poor outcome and mortality in critically ill patients in Switzerland. All adults with confirmed influenza admitted to the ICU at two Swiss tertiary care centres during the 2017/2018 influenza season were retrospectively evaluated. IAA was defined by clinical, mycological and radiological criteria: a positive galactomannan in bronchoalveolar lavage or histopathological or cultural evidence in respiratory specimens of Aspergillus spp., any radiological infiltrate and a compatible clinical presentation. Poor outcome was defined as a composite of in-hospital mortality, ICU length of stay (LOS), invasive ventilation for > 7 days or extracorporeal membrane oxygenation. Of 81 patients with influenza in the ICU, 9 (11%) were diagnosed with IAA. All patients with IAA had poor outcome compared to 26 (36%) patients without IAA (p < 0.001). Median ICU-LOS and mortality were 17 vs. 3 days (p < 0.01) and 3/9 (33%) vs. 13/72 (18%; p = 0.37) in patients with vs. without IAA, respectively. Patients with IAA had significantly longer durations of antibiotic therapy, vasoactive support and mechanical ventilation. Aspergillus was the most common respiratory co-pathogen (9/40, 22%) followed by classical bacterial co-pathogens. IAA was not associated with classical risk factors. Aspergillus is a common superinfection in critically ill influenza patients associated with poor outcome and longer duration of organ supportive therapies. Given the absence of classical risk factors for aspergillosis, greater awareness is necessary, particularly in those requiring organ supportive therapies.
Keywords: Influenza; Influenza-associated aspergillosis; Intensive care unit; Invasive aspergillosis; Pneumonia.